Teva Parenteral Medicines, Inc.June 4, 2013

FDA 483 - Teva Parenteral Medicines, Inc. - June 04, 2013

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teva Parenteral Medicines, Inc.

Record Details

An FDA inspection of Teva Parenteral Medicines Inc in Irvine, CA, from May 29 to June 4, 2013, revealed a significant failure to perform thorough investigations into unexplained discrepancies. The firm did not properly identify root causes for issues such as unmaintained equipment (a clean compressed air filter) and the use of a non-validated test method for endotoxin analysis, indicating deficiencies in their quality system and control unit oversight.

Company: Teva Parenteral Medicines, Inc.
Inspection Date: June 4, 2013
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
People: Marcus F. Yambot (Senior Consumer Safety Officer )
Carla J. Lundi (Senior Consumer Safety Officer)

Open in Dashboard

ID · a341f217-c45e-4025-8a02-d53234f20847